Latest News and Press Releases
Want to stay updated on the latest news?
-
LOS ANGELES, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Skye Bioscience, Inc., (“Skye” or the “Company”) (NASDAQ: SKYE) investors of a class action on behalf of investors that...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options If you purchased or...
-
LOS ANGELES, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Skye Bioscience, Inc., (“Skye” or the "Company") (NASDAQ: SKYE) investors of a class action on behalf of investors that...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options If you purchased or acquired Skye...
-
New class action for Skye Bioscience, Inc. (SKYE) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/16/2026
-
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4,...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options If you purchased or...
-
New class action for Skye Bioscience, Inc. (SKYE) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/16/2026
-
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm